ARMISTICE CAPITAL, LLC

Q3 2024 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
259
Total value ($000)
$6,252,651
Net value change ($000)
-1,695,249 (-21.3%)
New positions
79
Sold out positions
72
Turnover %
16.7%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/14/2024 Next filing: 2/14/2025 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
PTCT 55,510 26.1%
TVTX 45,346 73.6%
INCY 38,229 35.8%
GRFS 34,921 70.2%
DPZ 30,735 240.4%
Inari Medical, Inc. 26,544 54.6%
BUD 23,601 48.4%
S 22,913 220.1%
FIVN 22,031 69.1%
PARAV 21,240 NEW
Top Reduces (Value $000, Stocks/ETFs)
NBIX -113,809 -84.5%
EXAS -59,154 -100.0%
KDP -49,635 -100.0%
SNY -39,355 -54.1%
GSK -36,329 -62.9%
CPB -31,848 -66.0%
MDGL -31,431 -74.8%
KVUE -28,876 -100.0%
KEL -26,045 -100.0%
CRL -24,598 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,428,844 (38.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None